P. Fishman, O. Merimski, E. Baharav, Y. Shoenfeld (1997)
Autoantibodies to tyrosinaseCancer, 79
K. Vora, Jeffrey Ravetch, Tim Manser (1997)
Amplified follicular immune complex deposition in mice lacking the Fc receptor gamma-chain does not alter maturation of the B cell response.Journal of immunology, 159 5
Elizabeth Jaffee, Drew Pardoll (1996)
Murine tumor antigens: is it worth the search?Current opinion in immunology, 8 5
A. Houghton (1994)
Cancer antigens: immune recognition of self and altered selfThe Journal of Experimental Medicine, 180
P. Duhra, A. Ilchyshyn (1991)
Prolonged survival in metastatic malignant melanoma associated with vitiligoClinical and Experimental Dermatology, 16
D. Sylvestre, R. Clynes, M. Ma, H. Warren, M. Carroll, J. Ravetch (1996)
Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient MiceThe Journal of Experimental Medicine, 184
J. Nordlund, J. Kirkwood, B. Forget, G. Milton, D. Albert, A. Lerner (1983)
Vitiligo in patients with metastatic melanoma: a good prognostic sign.Journal of the American Academy of Dermatology, 9 5
T. Takai, Min Li, D. Sylvestre, R. Clynes, J. Ravetch (1994)
FcR γ chain deletion results in pleiotrophic effector cell defectsCell, 76
S. Rosenberg, D. White (1996)
Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy, 19 1
B. Diamond, D. Yelton (1981)
A new Fc receptor on mouse macrophages binding IgG3The Journal of Experimental Medicine, 153
S. Hann, S. Koo, Jung‐Bin Kim, Y. Park (1996)
Detection of Antibodies to Human Melanoma Cells in Vitiligo and Alopecia Areata by Western Blot AnalysisThe Journal of Dermatology, 23
C. Naftzger, Yoshizumi Takechi, Hironobu Kohda, Isao Hara, S. Vijayasaradhi, Alan Houghton (1996)
Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.Proceedings of the National Academy of Sciences of the United States of America, 93 25
Philip Livingston, G. Wong, S. Adluri, Y. Tao, M. Padavan, R. Parente, C. Hanlon, M. Calves, F. Helling, G. Ritter (1994)
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 5
Diana Sylvestre, Jeffrey Ravetch (1994)
Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade.Science, 265 5175
O. Merimsky, Y. Shoenfeld, E. Baharav, M. Altomonte, S. Chaitchik, M. Maio, S. Ferrone, P. Fishman (1996)
Melanoma-associated hypopigmentation: where are the antibodies?American journal of clinical oncology, 19 6
R. Clynes, J. Ravetch (1995)
Cytotoxic antibodies trigger inflammation through Fc receptors.Immunity, 3 1
Jian Cui, Jean-Claude Bystryn (1995)
Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.Archives of dermatology, 131 3
O. Merimsky, E. Baharav, Y. Shoenfeld, S. Chaitchik, Rosa Tsigelman, D. Cohen-Aloro, P. Fishman (1996)
Anti-tyrosinase antibodies in malignant melanomaCancer Immunology, Immunotherapy, 42
I. Hara, Y. Takechi, A. Houghton (1995)
Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus proteinThe Journal of Experimental Medicine, 182
S. Vijayasaradhi, Brigitte Bouchard, Alan Houghton (1990)
The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene productThe Journal of Experimental Medicine, 171
Rongfu Wang, P. Robbins, Yutaka Kawakami, X. Kang, Steven Rosenberg (1995)
Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes [published erratum appears in J Exp Med 1995 Mar 1;181(3):1261]The Journal of Experimental Medicine, 181
S. Hann, J. Kim (1995)
Detection of antibodies to human melanoma cell in vitiligo by western blot analysis.Yonsei medical journal, 36 5
(1998)
Clynes et al
Y. Takechi, I. Hara, C. Naftzger, Y. Xu, A. Houghton (1996)
A melanosomal membrane protein is a cell surface target for melanoma therapy.Clinical cancer research : an official journal of the American Association for Cancer Research, 2 11
Proceedings of the National Academy of Sciences – Unpaywall
Published: Jan 20, 1998
Access the full text.
Sign up today, get DeepDyve free for 14 days.